Germany-based Insightec and Israel-based Siemens Healthineers entered into a strategic agreement to develop compatibility between Insightec's Exablate Neuro device and Siemans' clinical MRI systems.

Please provide your email address to receive an email when new articles are posted on . The FDA has granted approval to Insightec for Exablate Neuro, a new device for treating patients with advanced ...

HAIFA, Israel and WAUKESHA, Wisconsin, July 10, 2019 /PRNewswire/ -- GE Healthcare, a leader in medical technology and diagnostic and therapeutic imaging, and INSIGHTEC®, a global medical technology ...

Insightec Ltd. received U.S. FDA approval for use of its Exablate Neuro device to address severe motor symptoms in patients with Parkinson’s disease, offering a new option for patients who have not ...

Exablate neuro device Patients are awake and responsive during the whole treatment duration. The Food and Drug Administration (FDA) has expanded the approval of Exablate ® Neuro to include treatment ...

Patients with Parkinson’s disease achieved a significant improvement in their tremors, mobility, and other physical symptoms after having a minimally invasive procedure involving focused ultrasound, ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

BALTIMORE -- The other day, Melanie Carlson took her 5-year-old daughter shopping for a bathing suit. Since they couldn’t find a suit in the first store, they stopped by a second. Then, Carlson drove ...

HAIFA, Israel & MIAMI, March 9, 2022 /PRNewswire/ -- Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that it has received FDA ...